nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—ulcerative colitis	0.153	0.492	CbGaD
Nabumetone—osteoarthritis—Prednisone—ulcerative colitis	0.134	0.5	CpDpCtD
Nabumetone—osteoarthritis—Methylprednisolone—ulcerative colitis	0.134	0.5	CpDpCtD
Nabumetone—PTGS1—ulcerative colitis	0.101	0.323	CbGaD
Nabumetone—MPO—Mesalazine—ulcerative colitis	0.0746	0.236	CbGbCtD
Nabumetone—PTGS2—ulcerative colitis	0.0575	0.185	CbGaD
Nabumetone—PTGS2—Olsalazine—ulcerative colitis	0.0362	0.115	CbGbCtD
Nabumetone—PTGS2—Balsalazide—ulcerative colitis	0.0322	0.102	CbGbCtD
Nabumetone—PTGS1—Olsalazine—ulcerative colitis	0.0305	0.0967	CbGbCtD
Nabumetone—PTGS1—Balsalazide—ulcerative colitis	0.0272	0.0862	CbGbCtD
Nabumetone—PTGS2—Mesalazine—ulcerative colitis	0.0258	0.0816	CbGbCtD
Nabumetone—PTGS1—Mesalazine—ulcerative colitis	0.0218	0.0689	CbGbCtD
Nabumetone—MPO—superior mesenteric artery—ulcerative colitis	0.0192	0.78	CbGeAlD
Nabumetone—PTGS2—Sulfasalazine—ulcerative colitis	0.0144	0.0456	CbGbCtD
Nabumetone—PTGS2—Triamcinolone—ulcerative colitis	0.0144	0.0456	CbGbCtD
Nabumetone—PTGS2—Betamethasone—ulcerative colitis	0.0124	0.0391	CbGbCtD
Nabumetone—PTGS1—Sulfasalazine—ulcerative colitis	0.0122	0.0385	CbGbCtD
Nabumetone—PTGS2—Dexamethasone—ulcerative colitis	0.00718	0.0228	CbGbCtD
Nabumetone—CYP1A2—Nicotine—ulcerative colitis	0.00698	0.0221	CbGbCtD
Nabumetone—MPO—IL23-mediated signaling events—IL23R—ulcerative colitis	0.0013	0.0594	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL18RAP—ulcerative colitis	0.00124	0.0567	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL23A—ulcerative colitis	0.0011	0.0505	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.00101	0.0465	CbGpPWpGaD
Nabumetone—Melatonin—CALM3—ulcerative colitis	0.000921	0.525	CrCbGaD
Nabumetone—MPO—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000888	0.0407	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000806	0.0369	CbGpPWpGaD
Nabumetone—MPO—epithelium—ulcerative colitis	0.000778	0.0316	CbGeAlD
Nabumetone—MPO—lymphoid tissue—ulcerative colitis	0.000599	0.0244	CbGeAlD
Nabumetone—MPO—digestive system—ulcerative colitis	0.000592	0.0241	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IL17A—ulcerative colitis	0.000516	0.0236	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000488	0.0224	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL12B—ulcerative colitis	0.00048	0.022	CbGpPWpGaD
Nabumetone—MPO—liver—ulcerative colitis	0.000441	0.0179	CbGeAlD
Nabumetone—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000374	0.247	CbGdCrCtD
Nabumetone—PTGS1—epithelium—ulcerative colitis	0.000369	0.015	CbGeAlD
Nabumetone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000365	0.0167	CbGpPWpGaD
Nabumetone—PTGS1—smooth muscle tissue—ulcerative colitis	0.000356	0.0145	CbGeAlD
Nabumetone—PTGS2—epithelium—ulcerative colitis	0.000353	0.0143	CbGeAlD
Nabumetone—PTGS2—smooth muscle tissue—ulcerative colitis	0.00034	0.0138	CbGeAlD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000331	0.0152	CbGpPWpGaD
Nabumetone—CYP1A2—digestive system—ulcerative colitis	0.000324	0.0132	CbGeAlD
Nabumetone—Melatonin—MPO—ulcerative colitis	0.000323	0.184	CrCbGaD
Nabumetone—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000289	0.0132	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000286	0.0131	CbGpPWpGaD
Nabumetone—PTGS1—digestive system—ulcerative colitis	0.000281	0.0114	CbGeAlD
Nabumetone—PTGS2—lymphoid tissue—ulcerative colitis	0.000272	0.011	CbGeAlD
Nabumetone—PTGS2—digestive system—ulcerative colitis	0.000269	0.0109	CbGeAlD
Nabumetone—MPO—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000258	0.0118	CbGpPWpGaD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000254	0.0116	CbGpPWpGaD
Nabumetone—Naproxen—PTGS1—ulcerative colitis	0.000246	0.14	CrCbGaD
Nabumetone—CYP1A2—liver—ulcerative colitis	0.000241	0.00981	CbGeAlD
Nabumetone—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000237	0.0109	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—CRP—ulcerative colitis	0.000228	0.0105	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—JAK2—ulcerative colitis	0.00021	0.00963	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	0.00021	0.00961	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IFNG—ulcerative colitis	0.000206	0.00945	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000206	0.00942	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—RELA—ulcerative colitis	0.000204	0.00932	CbGpPWpGaD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000201	0.00922	CbGpPWpGaD
Nabumetone—PTGS2—liver—ulcerative colitis	0.0002	0.00813	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—CD4—ulcerative colitis	0.000199	0.00913	CbGpPWpGaD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000198	0.00908	CbGpPWpGaD
Nabumetone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.00019	0.00868	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—CRP—ulcerative colitis	0.000186	0.0085	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL1B—ulcerative colitis	0.000184	0.00843	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.000184	0.0084	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL2—ulcerative colitis	0.000183	0.0084	CbGpPWpGaD
Nabumetone—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000181	0.119	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000178	0.118	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000178	0.118	CbGdCrCtD
Nabumetone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000176	0.00807	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—ALB—ulcerative colitis	0.000175	0.00801	CbGpPWpGaD
Nabumetone—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000174	0.115	CbGdCrCtD
Nabumetone—MPO—IL23-mediated signaling events—NFKB1—ulcerative colitis	0.000172	0.00786	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—ICAM1—ulcerative colitis	0.000171	0.00782	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000163	0.00748	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IFNG—ulcerative colitis	0.00016	0.00731	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—RELA—ulcerative colitis	0.000158	0.00721	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—STAT3—ulcerative colitis	0.000154	0.00707	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—CRP—ulcerative colitis	0.000148	0.00676	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IL1B—ulcerative colitis	0.000142	0.00652	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—ALB—ulcerative colitis	0.000142	0.00652	CbGpPWpGaD
Nabumetone—Naproxen—PTGS2—ulcerative colitis	0.000141	0.08	CrCbGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	0.000138	0.00632	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.000136	0.00621	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000134	0.00613	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—TNF—ulcerative colitis	0.000134	0.00612	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	0.000133	0.00608	CbGpPWpGaD
Nabumetone—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000132	0.00604	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IFNG—ulcerative colitis	0.00013	0.00595	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—RELA—ulcerative colitis	0.000128	0.00587	CbGpPWpGaD
Nabumetone—Naproxen—ALB—ulcerative colitis	0.000125	0.0713	CrCbGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	0.000119	0.00544	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL1B—ulcerative colitis	0.000116	0.00531	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL2—ulcerative colitis	0.000115	0.00529	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	0.000115	0.00528	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000115	0.00526	CbGpPWpGaD
Nabumetone—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	0.000114	0.00524	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—ALB—ulcerative colitis	0.000113	0.00518	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	0.000111	0.00509	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000109	0.0721	CbGdCrCtD
Nabumetone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.000109	0.005	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—NFKB1—ulcerative colitis	0.000108	0.00495	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL6—ulcerative colitis	0.000108	0.00494	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000107	0.0709	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000107	0.0709	CbGdCrCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000106	0.00487	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000105	0.0693	CbGdCrCtD
Nabumetone—MPO—C-MYB transcription factor network—CD4—ulcerative colitis	0.000103	0.00474	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—TNF—ulcerative colitis	0.000103	0.00473	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IFNG—ulcerative colitis	0.000103	0.00473	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—PTGS2—ulcerative colitis	0.000103	0.0047	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—RELA—ulcerative colitis	0.000102	0.00466	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—PTGS2—ulcerative colitis	9.89e-05	0.00453	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	9.64e-05	0.00441	CbGpPWpGaD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	9.58e-05	0.00439	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	9.46e-05	0.00433	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	9.32e-05	0.00427	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IL1B—ulcerative colitis	9.2e-05	0.00421	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	9.11e-05	0.00417	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—NFKB1—ulcerative colitis	8.59e-05	0.00393	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—TNF—ulcerative colitis	8.41e-05	0.00385	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	8.39e-05	0.00384	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IL6—ulcerative colitis	8.34e-05	0.00382	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	8.15e-05	0.00373	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	7.52e-05	0.00344	CbGpPWpGaD
Nabumetone—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	7.46e-05	0.00342	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	7.41e-05	0.00339	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—TP53—ulcerative colitis	7.41e-05	0.00339	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	7.4e-05	0.00339	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	7.3e-05	0.00334	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	7.24e-05	0.00332	CbGpPWpGaD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.11e-05	0.00326	CbGpPWpGaD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.1e-05	0.00325	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL6—ulcerative colitis	6.78e-05	0.00311	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—TNF—ulcerative colitis	6.68e-05	0.00306	CbGpPWpGaD
Nabumetone—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	6.55e-05	0.003	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	6.42e-05	0.00294	CbGpPWpGaD
Nabumetone—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	6.36e-05	0.00291	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	6.04e-05	0.00276	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	5.97e-05	0.00273	CbGpPWpGaD
Nabumetone—Angioedema—Hydrocortisone—ulcerative colitis	5.69e-05	0.00103	CcSEcCtD
Nabumetone—Urticaria—Mesalazine—ulcerative colitis	5.68e-05	0.00103	CcSEcCtD
Nabumetone—Abdominal pain—Mesalazine—ulcerative colitis	5.65e-05	0.00103	CcSEcCtD
Nabumetone—Body temperature increased—Mesalazine—ulcerative colitis	5.65e-05	0.00103	CcSEcCtD
Nabumetone—Malaise—Hydrocortisone—ulcerative colitis	5.62e-05	0.00102	CcSEcCtD
Nabumetone—Loss of consciousness—Prednisolone—ulcerative colitis	5.61e-05	0.00102	CcSEcCtD
Nabumetone—Vertigo—Hydrocortisone—ulcerative colitis	5.6e-05	0.00102	CcSEcCtD
Nabumetone—Vomiting—Budesonide—ulcerative colitis	5.59e-05	0.00102	CcSEcCtD
Nabumetone—Syncope—Hydrocortisone—ulcerative colitis	5.59e-05	0.00101	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	5.56e-05	0.00254	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	5.55e-05	0.00254	CbGpPWpGaD
Nabumetone—Rash—Budesonide—ulcerative colitis	5.54e-05	0.00101	CcSEcCtD
Nabumetone—Dermatitis—Budesonide—ulcerative colitis	5.54e-05	0.00101	CcSEcCtD
Nabumetone—Headache—Budesonide—ulcerative colitis	5.51e-05	0.001	CcSEcCtD
Nabumetone—Hypertension—Prednisolone—ulcerative colitis	5.51e-05	0.001	CcSEcCtD
Nabumetone—Loss of consciousness—Hydrocortisone—ulcerative colitis	5.48e-05	0.000994	CcSEcCtD
Nabumetone—Arrhythmia—Betamethasone—ulcerative colitis	5.46e-05	0.000992	CcSEcCtD
Nabumetone—Arrhythmia—Dexamethasone—ulcerative colitis	5.46e-05	0.000992	CcSEcCtD
Nabumetone—Ill-defined disorder—Triamcinolone—ulcerative colitis	5.44e-05	0.000988	CcSEcCtD
Nabumetone—Ill-defined disorder—Methylprednisolone—ulcerative colitis	5.43e-05	0.000986	CcSEcCtD
Nabumetone—Alopecia—Dexamethasone—ulcerative colitis	5.4e-05	0.000981	CcSEcCtD
Nabumetone—Alopecia—Betamethasone—ulcerative colitis	5.4e-05	0.000981	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—ulcerative colitis	5.39e-05	0.00247	CbGpPWpGaD
Nabumetone—Hypertension—Hydrocortisone—ulcerative colitis	5.38e-05	0.000977	CcSEcCtD
Nabumetone—Diarrhoea—Azathioprine—ulcerative colitis	5.37e-05	0.000975	CcSEcCtD
Nabumetone—Discomfort—Prednisolone—ulcerative colitis	5.37e-05	0.000974	CcSEcCtD
Nabumetone—Angioedema—Triamcinolone—ulcerative colitis	5.36e-05	0.000973	CcSEcCtD
Nabumetone—Haemoglobin—Prednisone—ulcerative colitis	5.35e-05	0.000972	CcSEcCtD
Nabumetone—Angioedema—Methylprednisolone—ulcerative colitis	5.35e-05	0.000971	CcSEcCtD
Nabumetone—Haemorrhage—Prednisone—ulcerative colitis	5.32e-05	0.000967	CcSEcCtD
Nabumetone—Malaise—Triamcinolone—ulcerative colitis	5.29e-05	0.000961	CcSEcCtD
Nabumetone—Anxiety—Hydrocortisone—ulcerative colitis	5.29e-05	0.00096	CcSEcCtD
Nabumetone—Malaise—Methylprednisolone—ulcerative colitis	5.28e-05	0.000958	CcSEcCtD
Nabumetone—Vertigo—Triamcinolone—ulcerative colitis	5.27e-05	0.000957	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	5.27e-05	0.00241	CbGpPWpGaD
Nabumetone—Hypersensitivity—Mesalazine—ulcerative colitis	5.27e-05	0.000957	CcSEcCtD
Nabumetone—Syncope—Triamcinolone—ulcerative colitis	5.26e-05	0.000955	CcSEcCtD
Nabumetone—Vertigo—Methylprednisolone—ulcerative colitis	5.26e-05	0.000955	CcSEcCtD
Nabumetone—Syncope—Methylprednisolone—ulcerative colitis	5.25e-05	0.000953	CcSEcCtD
Nabumetone—Discomfort—Hydrocortisone—ulcerative colitis	5.24e-05	0.000952	CcSEcCtD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.23e-05	0.00239	CbGpPWpGaD
Nabumetone—Nausea—Budesonide—ulcerative colitis	5.22e-05	0.000948	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisolone—ulcerative colitis	5.21e-05	0.000945	CcSEcCtD
Nabumetone—Oedema—Prednisolone—ulcerative colitis	5.21e-05	0.000945	CcSEcCtD
Nabumetone—Dizziness—Azathioprine—ulcerative colitis	5.19e-05	0.000943	CcSEcCtD
Nabumetone—Loss of consciousness—Triamcinolone—ulcerative colitis	5.16e-05	0.000936	CcSEcCtD
Nabumetone—Loss of consciousness—Methylprednisolone—ulcerative colitis	5.14e-05	0.000934	CcSEcCtD
Nabumetone—Asthenia—Mesalazine—ulcerative colitis	5.13e-05	0.000932	CcSEcCtD
Nabumetone—Shock—Prednisolone—ulcerative colitis	5.12e-05	0.00093	CcSEcCtD
Nabumetone—Cough—Triamcinolone—ulcerative colitis	5.12e-05	0.00093	CcSEcCtD
Nabumetone—Oedema—Hydrocortisone—ulcerative colitis	5.08e-05	0.000923	CcSEcCtD
Nabumetone—Anaphylactic shock—Hydrocortisone—ulcerative colitis	5.08e-05	0.000923	CcSEcCtD
Nabumetone—Hypertension—Triamcinolone—ulcerative colitis	5.06e-05	0.00092	CcSEcCtD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	5.06e-05	0.00232	CbGpPWpGaD
Nabumetone—Pruritus—Mesalazine—ulcerative colitis	5.06e-05	0.000919	CcSEcCtD
Nabumetone—Hypertension—Methylprednisolone—ulcerative colitis	5.05e-05	0.000918	CcSEcCtD
Nabumetone—Hyperhidrosis—Prednisolone—ulcerative colitis	5.03e-05	0.000914	CcSEcCtD
Nabumetone—Shock—Hydrocortisone—ulcerative colitis	5e-05	0.000908	CcSEcCtD
Nabumetone—Vomiting—Azathioprine—ulcerative colitis	4.99e-05	0.000906	CcSEcCtD
Nabumetone—Anxiety—Methylprednisolone—ulcerative colitis	4.97e-05	0.000902	CcSEcCtD
Nabumetone—Rash—Azathioprine—ulcerative colitis	4.95e-05	0.000899	CcSEcCtD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	4.95e-05	0.00227	CbGpPWpGaD
Nabumetone—Dermatitis—Azathioprine—ulcerative colitis	4.94e-05	0.000898	CcSEcCtD
Nabumetone—Ill-defined disorder—Betamethasone—ulcerative colitis	4.94e-05	0.000897	CcSEcCtD
Nabumetone—Ill-defined disorder—Dexamethasone—ulcerative colitis	4.94e-05	0.000897	CcSEcCtD
Nabumetone—Discomfort—Triamcinolone—ulcerative colitis	4.93e-05	0.000896	CcSEcCtD
Nabumetone—Discomfort—Methylprednisolone—ulcerative colitis	4.92e-05	0.000894	CcSEcCtD
Nabumetone—Headache—Azathioprine—ulcerative colitis	4.92e-05	0.000893	CcSEcCtD
Nabumetone—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.91e-05	0.000893	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	4.9e-05	0.00224	CbGpPWpGaD
Nabumetone—Diarrhoea—Mesalazine—ulcerative colitis	4.89e-05	0.000888	CcSEcCtD
Nabumetone—Dry mouth—Triamcinolone—ulcerative colitis	4.88e-05	0.000887	CcSEcCtD
Nabumetone—Angioedema—Betamethasone—ulcerative colitis	4.86e-05	0.000883	CcSEcCtD
Nabumetone—Angioedema—Dexamethasone—ulcerative colitis	4.86e-05	0.000883	CcSEcCtD
Nabumetone—Anorexia—Hydrocortisone—ulcerative colitis	4.85e-05	0.00088	CcSEcCtD
Nabumetone—Confusional state—Methylprednisolone—ulcerative colitis	4.82e-05	0.000875	CcSEcCtD
Nabumetone—Malaise—Dexamethasone—ulcerative colitis	4.8e-05	0.000872	CcSEcCtD
Nabumetone—Malaise—Betamethasone—ulcerative colitis	4.8e-05	0.000872	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	4.79e-05	0.00219	CbGpPWpGaD
Nabumetone—Oedema—Triamcinolone—ulcerative colitis	4.79e-05	0.000869	CcSEcCtD
Nabumetone—Anaphylactic shock—Triamcinolone—ulcerative colitis	4.79e-05	0.000869	CcSEcCtD
Nabumetone—Vertigo—Dexamethasone—ulcerative colitis	4.78e-05	0.000868	CcSEcCtD
Nabumetone—Vertigo—Betamethasone—ulcerative colitis	4.78e-05	0.000868	CcSEcCtD
Nabumetone—Anaphylactic shock—Methylprednisolone—ulcerative colitis	4.78e-05	0.000867	CcSEcCtD
Nabumetone—Syncope—Betamethasone—ulcerative colitis	4.77e-05	0.000867	CcSEcCtD
Nabumetone—Syncope—Dexamethasone—ulcerative colitis	4.77e-05	0.000867	CcSEcCtD
Nabumetone—Arrhythmia—Prednisone—ulcerative colitis	4.76e-05	0.000864	CcSEcCtD
Nabumetone—Dizziness—Mesalazine—ulcerative colitis	4.73e-05	0.000859	CcSEcCtD
Nabumetone—Shock—Triamcinolone—ulcerative colitis	4.71e-05	0.000855	CcSEcCtD
Nabumetone—Insomnia—Prednisolone—ulcerative colitis	4.71e-05	0.000855	CcSEcCtD
Nabumetone—Alopecia—Prednisone—ulcerative colitis	4.7e-05	0.000854	CcSEcCtD
Nabumetone—Shock—Methylprednisolone—ulcerative colitis	4.7e-05	0.000853	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	4.69e-05	0.00215	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	4.68e-05	0.00214	CbGpPWpGaD
Nabumetone—Loss of consciousness—Dexamethasone—ulcerative colitis	4.68e-05	0.000849	CcSEcCtD
Nabumetone—Loss of consciousness—Betamethasone—ulcerative colitis	4.68e-05	0.000849	CcSEcCtD
Nabumetone—Paraesthesia—Prednisolone—ulcerative colitis	4.67e-05	0.000849	CcSEcCtD
Nabumetone—Nausea—Azathioprine—ulcerative colitis	4.66e-05	0.000847	CcSEcCtD
Nabumetone—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.63e-05	0.00084	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	4.63e-05	0.00212	CbGpPWpGaD
Nabumetone—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.62e-05	0.000839	CcSEcCtD
Nabumetone—Insomnia—Hydrocortisone—ulcerative colitis	4.6e-05	0.000835	CcSEcCtD
Nabumetone—Hypertension—Dexamethasone—ulcerative colitis	4.59e-05	0.000834	CcSEcCtD
Nabumetone—Hypertension—Betamethasone—ulcerative colitis	4.59e-05	0.000834	CcSEcCtD
Nabumetone—Paraesthesia—Hydrocortisone—ulcerative colitis	4.57e-05	0.000829	CcSEcCtD
Nabumetone—Vomiting—Mesalazine—ulcerative colitis	4.55e-05	0.000826	CcSEcCtD
Nabumetone—Anxiety—Dexamethasone—ulcerative colitis	4.52e-05	0.00082	CcSEcCtD
Nabumetone—Anxiety—Betamethasone—ulcerative colitis	4.52e-05	0.00082	CcSEcCtD
Nabumetone—Rash—Mesalazine—ulcerative colitis	4.51e-05	0.000819	CcSEcCtD
Nabumetone—Dermatitis—Mesalazine—ulcerative colitis	4.5e-05	0.000818	CcSEcCtD
Nabumetone—Headache—Mesalazine—ulcerative colitis	4.48e-05	0.000813	CcSEcCtD
Nabumetone—Discomfort—Dexamethasone—ulcerative colitis	4.48e-05	0.000813	CcSEcCtD
Nabumetone—Discomfort—Betamethasone—ulcerative colitis	4.48e-05	0.000813	CcSEcCtD
Nabumetone—Dyspepsia—Hydrocortisone—ulcerative colitis	4.48e-05	0.000813	CcSEcCtD
Nabumetone—Decreased appetite—Hydrocortisone—ulcerative colitis	4.42e-05	0.000803	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	4.41e-05	0.00202	CbGpPWpGaD
Nabumetone—Fatigue—Hydrocortisone—ulcerative colitis	4.38e-05	0.000796	CcSEcCtD
Nabumetone—Oedema—Dexamethasone—ulcerative colitis	4.34e-05	0.000789	CcSEcCtD
Nabumetone—Anaphylactic shock—Betamethasone—ulcerative colitis	4.34e-05	0.000789	CcSEcCtD
Nabumetone—Oedema—Betamethasone—ulcerative colitis	4.34e-05	0.000789	CcSEcCtD
Nabumetone—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.34e-05	0.000789	CcSEcCtD
Nabumetone—Insomnia—Triamcinolone—ulcerative colitis	4.33e-05	0.000786	CcSEcCtD
Nabumetone—Insomnia—Methylprednisolone—ulcerative colitis	4.32e-05	0.000785	CcSEcCtD
Nabumetone—Ill-defined disorder—Prednisone—ulcerative colitis	4.3e-05	0.000781	CcSEcCtD
Nabumetone—Paraesthesia—Triamcinolone—ulcerative colitis	4.3e-05	0.000781	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisolone—ulcerative colitis	4.29e-05	0.000779	CcSEcCtD
Nabumetone—Paraesthesia—Methylprednisolone—ulcerative colitis	4.29e-05	0.000779	CcSEcCtD
Nabumetone—Anaemia—Prednisone—ulcerative colitis	4.28e-05	0.000778	CcSEcCtD
Nabumetone—Shock—Betamethasone—ulcerative colitis	4.27e-05	0.000776	CcSEcCtD
Nabumetone—Shock—Dexamethasone—ulcerative colitis	4.27e-05	0.000776	CcSEcCtD
Nabumetone—Dyspnoea—Triamcinolone—ulcerative colitis	4.27e-05	0.000775	CcSEcCtD
Nabumetone—Agitation—Prednisone—ulcerative colitis	4.26e-05	0.000774	CcSEcCtD
Nabumetone—Thrombocytopenia—Betamethasone—ulcerative colitis	4.25e-05	0.000772	CcSEcCtD
Nabumetone—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.25e-05	0.000772	CcSEcCtD
Nabumetone—Nausea—Mesalazine—ulcerative colitis	4.25e-05	0.000771	CcSEcCtD
Nabumetone—Angioedema—Prednisone—ulcerative colitis	4.24e-05	0.000769	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	4.22e-05	0.00193	CbGpPWpGaD
Nabumetone—Dyspepsia—Triamcinolone—ulcerative colitis	4.21e-05	0.000765	CcSEcCtD
Nabumetone—Dyspepsia—Methylprednisolone—ulcerative colitis	4.2e-05	0.000764	CcSEcCtD
Nabumetone—Hyperhidrosis—Betamethasone—ulcerative colitis	4.2e-05	0.000763	CcSEcCtD
Nabumetone—Hyperhidrosis—Dexamethasone—ulcerative colitis	4.2e-05	0.000763	CcSEcCtD
Nabumetone—Feeling abnormal—Hydrocortisone—ulcerative colitis	4.19e-05	0.000761	CcSEcCtD
Nabumetone—Malaise—Prednisone—ulcerative colitis	4.18e-05	0.000759	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	4.17e-05	0.00191	CbGpPWpGaD
Nabumetone—Vertigo—Prednisone—ulcerative colitis	4.16e-05	0.000756	CcSEcCtD
Nabumetone—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.16e-05	0.000755	CcSEcCtD
Nabumetone—Syncope—Prednisone—ulcerative colitis	4.16e-05	0.000755	CcSEcCtD
Nabumetone—Anorexia—Dexamethasone—ulcerative colitis	4.14e-05	0.000752	CcSEcCtD
Nabumetone—Anorexia—Betamethasone—ulcerative colitis	4.14e-05	0.000752	CcSEcCtD
Nabumetone—Urticaria—Prednisolone—ulcerative colitis	4.14e-05	0.000751	CcSEcCtD
Nabumetone—Fatigue—Triamcinolone—ulcerative colitis	4.13e-05	0.00075	CcSEcCtD
Nabumetone—Fatigue—Methylprednisolone—ulcerative colitis	4.12e-05	0.000748	CcSEcCtD
Nabumetone—Loss of consciousness—Prednisone—ulcerative colitis	4.07e-05	0.00074	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	4.05e-05	0.00185	CbGpPWpGaD
Nabumetone—Urticaria—Hydrocortisone—ulcerative colitis	4.04e-05	0.000733	CcSEcCtD
Nabumetone—Abdominal pain—Hydrocortisone—ulcerative colitis	4.02e-05	0.00073	CcSEcCtD
Nabumetone—Body temperature increased—Hydrocortisone—ulcerative colitis	4.02e-05	0.00073	CcSEcCtD
Nabumetone—Hypertension—Prednisone—ulcerative colitis	4e-05	0.000727	CcSEcCtD
Nabumetone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	4e-05	0.00183	CbGpPWpGaD
Nabumetone—Feeling abnormal—Triamcinolone—ulcerative colitis	3.94e-05	0.000716	CcSEcCtD
Nabumetone—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.94e-05	0.000715	CcSEcCtD
Nabumetone—Anxiety—Prednisone—ulcerative colitis	3.93e-05	0.000714	CcSEcCtD
Nabumetone—Insomnia—Betamethasone—ulcerative colitis	3.93e-05	0.000713	CcSEcCtD
Nabumetone—Insomnia—Dexamethasone—ulcerative colitis	3.93e-05	0.000713	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.91e-05	0.000709	CcSEcCtD
Nabumetone—Paraesthesia—Betamethasone—ulcerative colitis	3.9e-05	0.000708	CcSEcCtD
Nabumetone—Paraesthesia—Dexamethasone—ulcerative colitis	3.9e-05	0.000708	CcSEcCtD
Nabumetone—Discomfort—Prednisone—ulcerative colitis	3.9e-05	0.000708	CcSEcCtD
Nabumetone—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	3.84e-05	0.00176	CbGpPWpGaD
Nabumetone—Hypersensitivity—Prednisolone—ulcerative colitis	3.84e-05	0.000696	CcSEcCtD
Nabumetone—Dyspepsia—Dexamethasone—ulcerative colitis	3.82e-05	0.000694	CcSEcCtD
Nabumetone—Dyspepsia—Betamethasone—ulcerative colitis	3.82e-05	0.000694	CcSEcCtD
Nabumetone—Urticaria—Triamcinolone—ulcerative colitis	3.8e-05	0.000691	CcSEcCtD
Nabumetone—Urticaria—Methylprednisolone—ulcerative colitis	3.79e-05	0.000689	CcSEcCtD
Nabumetone—Body temperature increased—Triamcinolone—ulcerative colitis	3.78e-05	0.000687	CcSEcCtD
Nabumetone—Oedema—Prednisone—ulcerative colitis	3.78e-05	0.000687	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisone—ulcerative colitis	3.78e-05	0.000687	CcSEcCtD
Nabumetone—Abdominal pain—Methylprednisolone—ulcerative colitis	3.78e-05	0.000686	CcSEcCtD
Nabumetone—Decreased appetite—Dexamethasone—ulcerative colitis	3.78e-05	0.000686	CcSEcCtD
Nabumetone—Decreased appetite—Betamethasone—ulcerative colitis	3.78e-05	0.000686	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	3.77e-05	0.00172	CbGpPWpGaD
Nabumetone—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.75e-05	0.00068	CcSEcCtD
Nabumetone—Fatigue—Betamethasone—ulcerative colitis	3.74e-05	0.00068	CcSEcCtD
Nabumetone—Fatigue—Dexamethasone—ulcerative colitis	3.74e-05	0.00068	CcSEcCtD
Nabumetone—Shock—Prednisone—ulcerative colitis	3.72e-05	0.000676	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	3.67e-05	0.00168	CbGpPWpGaD
Nabumetone—Hyperhidrosis—Prednisone—ulcerative colitis	3.66e-05	0.000664	CcSEcCtD
Nabumetone—Asthenia—Hydrocortisone—ulcerative colitis	3.65e-05	0.000662	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	3.65e-05	0.00167	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	3.63e-05	0.00166	CbGpPWpGaD
Nabumetone—Anorexia—Prednisone—ulcerative colitis	3.61e-05	0.000655	CcSEcCtD
Nabumetone—Pruritus—Hydrocortisone—ulcerative colitis	3.6e-05	0.000653	CcSEcCtD
Nabumetone—Feeling abnormal—Betamethasone—ulcerative colitis	3.58e-05	0.00065	CcSEcCtD
Nabumetone—Feeling abnormal—Dexamethasone—ulcerative colitis	3.58e-05	0.00065	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.55e-05	0.000645	CcSEcCtD
Nabumetone—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.55e-05	0.000645	CcSEcCtD
Nabumetone—Hypersensitivity—Triamcinolone—ulcerative colitis	3.53e-05	0.00064	CcSEcCtD
Nabumetone—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.52e-05	0.000639	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	3.51e-05	0.00161	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	3.48e-05	0.0016	CbGpPWpGaD
Nabumetone—Diarrhoea—Hydrocortisone—ulcerative colitis	3.48e-05	0.000632	CcSEcCtD
Nabumetone—Urticaria—Betamethasone—ulcerative colitis	3.45e-05	0.000627	CcSEcCtD
Nabumetone—Urticaria—Dexamethasone—ulcerative colitis	3.45e-05	0.000627	CcSEcCtD
Nabumetone—Dizziness—Prednisolone—ulcerative colitis	3.44e-05	0.000625	CcSEcCtD
Nabumetone—Asthenia—Triamcinolone—ulcerative colitis	3.43e-05	0.000624	CcSEcCtD
Nabumetone—Abdominal pain—Betamethasone—ulcerative colitis	3.43e-05	0.000624	CcSEcCtD
Nabumetone—Body temperature increased—Betamethasone—ulcerative colitis	3.43e-05	0.000624	CcSEcCtD
Nabumetone—Abdominal pain—Dexamethasone—ulcerative colitis	3.43e-05	0.000624	CcSEcCtD
Nabumetone—Body temperature increased—Dexamethasone—ulcerative colitis	3.43e-05	0.000624	CcSEcCtD
Nabumetone—Asthenia—Methylprednisolone—ulcerative colitis	3.43e-05	0.000622	CcSEcCtD
Nabumetone—Insomnia—Prednisone—ulcerative colitis	3.42e-05	0.000621	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	3.41e-05	0.00156	CbGpPWpGaD
Nabumetone—Paraesthesia—Prednisone—ulcerative colitis	3.4e-05	0.000617	CcSEcCtD
Nabumetone—Pruritus—Triamcinolone—ulcerative colitis	3.39e-05	0.000615	CcSEcCtD
Nabumetone—Pruritus—Methylprednisolone—ulcerative colitis	3.38e-05	0.000614	CcSEcCtD
Nabumetone—Dizziness—Hydrocortisone—ulcerative colitis	3.36e-05	0.000611	CcSEcCtD
Nabumetone—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	3.36e-05	0.00154	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	3.35e-05	0.00154	CbGpPWpGaD
Nabumetone—Dyspepsia—Prednisone—ulcerative colitis	3.33e-05	0.000605	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	3.31e-05	0.00151	CbGpPWpGaD
Nabumetone—Decreased appetite—Prednisone—ulcerative colitis	3.29e-05	0.000597	CcSEcCtD
Nabumetone—Rash—Prednisolone—ulcerative colitis	3.28e-05	0.000596	CcSEcCtD
Nabumetone—Dermatitis—Prednisolone—ulcerative colitis	3.28e-05	0.000596	CcSEcCtD
Nabumetone—Diarrhoea—Methylprednisolone—ulcerative colitis	3.27e-05	0.000593	CcSEcCtD
Nabumetone—Fatigue—Prednisone—ulcerative colitis	3.26e-05	0.000592	CcSEcCtD
Nabumetone—Headache—Prednisolone—ulcerative colitis	3.26e-05	0.000592	CcSEcCtD
Nabumetone—Constipation—Prednisone—ulcerative colitis	3.23e-05	0.000587	CcSEcCtD
Nabumetone—Vomiting—Hydrocortisone—ulcerative colitis	3.23e-05	0.000587	CcSEcCtD
Nabumetone—Rash—Hydrocortisone—ulcerative colitis	3.21e-05	0.000582	CcSEcCtD
Nabumetone—Dermatitis—Hydrocortisone—ulcerative colitis	3.2e-05	0.000582	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	3.19e-05	0.00146	CbGpPWpGaD
Nabumetone—Headache—Hydrocortisone—ulcerative colitis	3.18e-05	0.000578	CcSEcCtD
Nabumetone—Dizziness—Triamcinolone—ulcerative colitis	3.17e-05	0.000575	CcSEcCtD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	3.16e-05	0.00145	CbGpPWpGaD
Nabumetone—Dizziness—Methylprednisolone—ulcerative colitis	3.16e-05	0.000574	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	3.14e-05	0.00144	CbGpPWpGaD
Nabumetone—Feeling abnormal—Prednisone—ulcerative colitis	3.12e-05	0.000566	CcSEcCtD
Nabumetone—Asthenia—Dexamethasone—ulcerative colitis	3.12e-05	0.000566	CcSEcCtD
Nabumetone—Asthenia—Betamethasone—ulcerative colitis	3.12e-05	0.000566	CcSEcCtD
Nabumetone—Gastrointestinal pain—Prednisone—ulcerative colitis	3.09e-05	0.000562	CcSEcCtD
Nabumetone—Nausea—Prednisolone—ulcerative colitis	3.09e-05	0.000562	CcSEcCtD
Nabumetone—Pruritus—Dexamethasone—ulcerative colitis	3.07e-05	0.000558	CcSEcCtD
Nabumetone—Pruritus—Betamethasone—ulcerative colitis	3.07e-05	0.000558	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	3.06e-05	0.0014	CbGpPWpGaD
Nabumetone—Vomiting—Triamcinolone—ulcerative colitis	3.04e-05	0.000553	CcSEcCtD
Nabumetone—Vomiting—Methylprednisolone—ulcerative colitis	3.04e-05	0.000552	CcSEcCtD
Nabumetone—Nausea—Hydrocortisone—ulcerative colitis	3.02e-05	0.000548	CcSEcCtD
Nabumetone—Rash—Triamcinolone—ulcerative colitis	3.02e-05	0.000548	CcSEcCtD
Nabumetone—Dermatitis—Triamcinolone—ulcerative colitis	3.02e-05	0.000548	CcSEcCtD
Nabumetone—Rash—Methylprednisolone—ulcerative colitis	3.01e-05	0.000547	CcSEcCtD
Nabumetone—Dermatitis—Methylprednisolone—ulcerative colitis	3.01e-05	0.000546	CcSEcCtD
Nabumetone—Urticaria—Prednisone—ulcerative colitis	3.01e-05	0.000546	CcSEcCtD
Nabumetone—Headache—Triamcinolone—ulcerative colitis	3e-05	0.000545	CcSEcCtD
Nabumetone—Headache—Methylprednisolone—ulcerative colitis	2.99e-05	0.000543	CcSEcCtD
Nabumetone—Body temperature increased—Prednisone—ulcerative colitis	2.99e-05	0.000543	CcSEcCtD
Nabumetone—Abdominal pain—Prednisone—ulcerative colitis	2.99e-05	0.000543	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	2.99e-05	0.00137	CbGpPWpGaD
Nabumetone—Diarrhoea—Dexamethasone—ulcerative colitis	2.97e-05	0.00054	CcSEcCtD
Nabumetone—Diarrhoea—Betamethasone—ulcerative colitis	2.97e-05	0.00054	CcSEcCtD
Nabumetone—Dizziness—Betamethasone—ulcerative colitis	2.87e-05	0.000522	CcSEcCtD
Nabumetone—Dizziness—Dexamethasone—ulcerative colitis	2.87e-05	0.000522	CcSEcCtD
Nabumetone—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.86e-05	0.00131	CbGpPWpGaD
Nabumetone—Nausea—Triamcinolone—ulcerative colitis	2.84e-05	0.000516	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	2.84e-05	0.0013	CbGpPWpGaD
Nabumetone—Nausea—Methylprednisolone—ulcerative colitis	2.84e-05	0.000515	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	2.83e-05	0.0013	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	2.79e-05	0.00128	CbGpPWpGaD
Nabumetone—Hypersensitivity—Prednisone—ulcerative colitis	2.79e-05	0.000506	CcSEcCtD
Nabumetone—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	2.78e-05	0.00127	CbGpPWpGaD
Nabumetone—Vomiting—Betamethasone—ulcerative colitis	2.76e-05	0.000502	CcSEcCtD
Nabumetone—Vomiting—Dexamethasone—ulcerative colitis	2.76e-05	0.000502	CcSEcCtD
Nabumetone—Rash—Betamethasone—ulcerative colitis	2.74e-05	0.000497	CcSEcCtD
Nabumetone—Rash—Dexamethasone—ulcerative colitis	2.74e-05	0.000497	CcSEcCtD
Nabumetone—Dermatitis—Dexamethasone—ulcerative colitis	2.74e-05	0.000497	CcSEcCtD
Nabumetone—Dermatitis—Betamethasone—ulcerative colitis	2.74e-05	0.000497	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	2.73e-05	0.00125	CbGpPWpGaD
Nabumetone—Headache—Betamethasone—ulcerative colitis	2.72e-05	0.000494	CcSEcCtD
Nabumetone—Headache—Dexamethasone—ulcerative colitis	2.72e-05	0.000494	CcSEcCtD
Nabumetone—Asthenia—Prednisone—ulcerative colitis	2.71e-05	0.000493	CcSEcCtD
Nabumetone—Pruritus—Prednisone—ulcerative colitis	2.68e-05	0.000486	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.65e-05	0.00121	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	2.65e-05	0.00121	CbGpPWpGaD
Nabumetone—Diarrhoea—Prednisone—ulcerative colitis	2.59e-05	0.00047	CcSEcCtD
Nabumetone—Nausea—Betamethasone—ulcerative colitis	2.58e-05	0.000469	CcSEcCtD
Nabumetone—Nausea—Dexamethasone—ulcerative colitis	2.58e-05	0.000469	CcSEcCtD
Nabumetone—PTGS1—Metabolism—CHP1—ulcerative colitis	2.53e-05	0.00116	CbGpPWpGaD
Nabumetone—Dizziness—Prednisone—ulcerative colitis	2.5e-05	0.000454	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	2.46e-05	0.00113	CbGpPWpGaD
Nabumetone—Vomiting—Prednisone—ulcerative colitis	2.41e-05	0.000437	CcSEcCtD
Nabumetone—PTGS2—Disease—CHP1—ulcerative colitis	2.4e-05	0.0011	CbGpPWpGaD
Nabumetone—Rash—Prednisone—ulcerative colitis	2.39e-05	0.000433	CcSEcCtD
Nabumetone—Dermatitis—Prednisone—ulcerative colitis	2.38e-05	0.000433	CcSEcCtD
Nabumetone—Headache—Prednisone—ulcerative colitis	2.37e-05	0.00043	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	2.36e-05	0.00108	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	2.36e-05	0.00108	CbGpPWpGaD
Nabumetone—Nausea—Prednisone—ulcerative colitis	2.25e-05	0.000408	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	2.23e-05	0.00102	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.21e-05	0.00101	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	2.21e-05	0.00101	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DLD—ulcerative colitis	2.19e-05	0.001	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	2.17e-05	0.000994	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.06e-05	0.000945	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.06e-05	0.000945	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CHP1—ulcerative colitis	2.01e-05	0.000921	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SEL1L—ulcerative colitis	1.91e-05	0.000873	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.88e-05	0.000863	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	1.84e-05	0.000841	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	1.75e-05	0.000802	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DLD—ulcerative colitis	1.74e-05	0.000795	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	1.72e-05	0.000786	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LTF—ulcerative colitis	1.71e-05	0.000783	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	1.51e-05	0.000693	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.5e-05	0.000687	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	1.38e-05	0.000634	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.25e-05	0.000572	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC11A1—ulcerative colitis	1.22e-05	0.000558	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.17e-05	0.000535	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.16e-05	0.000529	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.14e-05	0.000521	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAML2—ulcerative colitis	1.1e-05	0.000502	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.07e-05	0.000488	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.04e-05	0.000476	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.03e-05	0.000471	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DLD—ulcerative colitis	9.82e-06	0.00045	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CALM3—ulcerative colitis	9.52e-06	0.000436	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.18e-06	0.00042	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.09e-06	0.000416	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CALM3—ulcerative colitis	9.02e-06	0.000413	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PTGS1—ulcerative colitis	8.39e-06	0.000384	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.25e-06	0.000378	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CALM3—ulcerative colitis	7.55e-06	0.000346	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCB1—ulcerative colitis	7.4e-06	0.000339	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADCY5—ulcerative colitis	6.9e-06	0.000316	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADCY5—ulcerative colitis	6.54e-06	0.0003	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCB1—ulcerative colitis	5.87e-06	0.000269	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADCY5—ulcerative colitis	5.48e-06	0.000251	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.19e-06	0.000238	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—ulcerative colitis	5.15e-06	0.000236	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS1—ulcerative colitis	4.75e-06	0.000217	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.67e-06	0.000214	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—ulcerative colitis	4.63e-06	0.000212	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.27e-06	0.000196	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—ulcerative colitis	4.09e-06	0.000187	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.09e-06	0.000187	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JAK2—ulcerative colitis	4.08e-06	0.000187	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—ulcerative colitis	4.05e-06	0.000185	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—ulcerative colitis	3.87e-06	0.000177	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—ulcerative colitis	3.68e-06	0.000168	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.32e-06	0.000152	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.1e-06	0.000142	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—ulcerative colitis	2.99e-06	0.000137	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—ulcerative colitis	2.78e-06	0.000127	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.31e-06	0.000106	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—ulcerative colitis	2.09e-06	9.58e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—ulcerative colitis	2.08e-06	9.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.82e-06	8.33e-05	CbGpPWpGaD
